In the embryo, Shh, together with Wnts, regulates multiple aspects of normal myogenesis, including the expression of myogenic regulatory factors
, the development, survival and proliferation of the epaxial and hypaxial muscle lineages, and the selection of muscle fibre types [2, 3] . The Shh pathway is considered generally silent in post-natal life. However, we have previously demonstrated that ischaemia is able to reactivate the Shh pathway in the adult skeletal muscle and myocardium [4, 5] . We have also shown that exogenous administration of Shh might have beneficial effects in experimental models of hindlimb ischaemia, myocardial infarction and diabetic peripheral neuropathy [5] [6] [7] . In the present study, we evaluated whether the Hh pathway is important for the regeneration of injured skeletal muscles in the adult. We investigated the possibility that the Hh pathway is post-natally reactivated upon non-ischaemic muscular injuries and studied its functional role on angiogenesis and myogenesis during muscle regeneration. [4] [5] [6] [7] . Two injury models were used: (i ) mechanical crush and (ii ) cardiotoxin (CTX) injection of the tibialis anterior (TA) muscle. Injuries were carried out as previously described [8, 9] . In both models, contralateral muscles were used as internal controls. Mice were [8] [9] [10] [11] [12] 
Materials and methods

Animals and models of muscle injury
C57BL/6J mice were from Jackson Labs. NLS-Ptc1-LacZ mice were kindly provided by Dr. Matthew Scott, Stanford University, Stanford, CA. NLSPtc1-LlacZ mice carry a non-disruptive insertion of the LacZ reporter gene containing a nuclear localization signal (NLS) upstream of the Ptc1 coding region. Ptc1 expression corresponds to LacZ expression in post-natal tissues and is not altered by LacZ insertion
Real-time (RT) PCR
Muscles were harvested at different time-points after injury. RT-PCR was performed as described previously [4] . Results are presented as average fold-induction of gene expression in injured muscles, compared to contralateral tissues.
In situ hybridization
Skeletal muscles were harvested 2 days after injury and immediately immersion fixed overnight in 4% paraformaldehyde, paraffin-embedded and sectioned longitudinally at 7-8 m. Shh in situ hybridization was performed with digoxigenin-labelled sense and antisense cRNA probes, as previously described [4] .
LacZ immunofluorescence and histochemistry in nls-Ptc1-lacZ Mice
These analyses were performed 4 days after CTX injury. Staining was done as described previously [4] [5] [6] [7] . Briefly [14] . All experiments were performed in triplicate. [7, 16] . Fibrosis was evaluated by Van Gieson staining, as previously reported [5] . ET was determined by Gomori's Trichrome staining, as previously described [17] . Results are presented as ratio between injured and contralateral muscles. Calculations were done on five sections per muscle. Analyses were performed in a blinded fashion by two independent investigators.
In vivo inhibition of the Shh pathway
Regional blood flow
Mice treated with cyclopamine or saline underwent evaluation of regional blood flow of the TA muscle by laser Doppler flowmetry (PeriFlux System 5002, Perimed, Richmond, VA, USA), performed in triplicate in three different areas of the muscle, before CTX injection and at different time-points after injury, as previously described [4, 6] . Results are presented as ratio between injured and contralateral muscles. Analyses were performed in a blinded fashion by two independent investigators. 
Motor function
Statistical analyses
Results are expressed as mean Ϯ S.D. Group differences were analysed by Student's t-test. Differences were considered statistically significant at a value of P < 0.05.
Results
Post-natal recapitulation of the Shh pathway in injured and regenerating skeletal muscle
Two days after mechanical crush, there was a significant increase in Shh mRNA level in injured TA compared to contralateral muscle (Fig. 1A) . At this time-point, also muscles injured with CTX exhibited a significant increase of Shh mRNA (Fig. 1B) . In both models, Shh mRNA remained significantly higher in injured muscles at day 4 and 7 after injury ( Fig. 1A and B) . At day 10, Shh mRNA expression was not different in injured and control tissues ( Fig. 1A [4] [5] [6] [7] , the mRNA levels of this gene were also analysed. We found that both mechanical and toxic injuries of the skeletal muscle were followed by significant up-regulation of Ptc1 mRNA. This effect was detectable at day 2, 4 and 7 after injury, with the highest expression level being observed at day 4, when Ptc1 mRNA was increased about 5 fold in injured muscles, compared to controls ( Fig. 1G and H) .
and B). No significant modification of Ihh and Dhh expression was documented in crushed and CTX-injected TA at any of the investigated time-points (Fig. 1C-F). Since Ptc1 is a Shh-target gene and its expression constitutes evidence of Shh activity
In order to identify the source of Shh production in injured skeletal muscles, we performed in situ hybridization analyses. Two days after both mechanical crush and CTX injection, a strong Shhpositive signal was detected in skeletal muscle fibres surrounding the injured area ( Fig. 2A and B) . These findings indicate that surviving skeletal muscle fibres are responsible for Shh production following injury. (Fig. 3A) . Similarly, the up-regulation of SDF-1alpha was significantly reduced in injured muscles of mice treated with cyclopamine (Fig. 3B) . Following these observations, we hypothesized that the negative effects of Shh inhibition on the expression levels of VEGF and SDF-1alpha could be mirrored by a decrement of the angiogenic response that physiologically follows muscle injury. As hypothesized, capillary density was reduced upon inhibition of the Shh pathway (Fig. 3C and D) . Injured muscles of cyclopamine-treated mice displayed 49 Ϯ 10 vessels/section, compared to 88 Ϯ 7 vessels/section of muscles of saline-treated animals (P < 0.01) (Fig. 3E) . Likewise, laser Doppler flowmetry showed profound alterations of muscle blood flow in animals treated with cyclopamine (Fig. 3F) . (Fig. 4B  and C) . Also the number of activated satellite cells in the site of injury, identified as cells expressing either Myf5 or MyoD, was significantly reduced in the muscles of mice treated with cyclopamine ( Fig. 4D and E) . (Fig. 5A and [4] [5] [6] [7] , X-gal-positive cells represent Shh-responding elements. By performing double immunofluorescent analyses for Myf5 and MyoD, we found that several ␤-gal-positive cells were also immunopositive for these MRFs (Fig. 5C and D (Fig. 5E ). This effect was significantly reduced by cyclopamine (Fig. 5E ).
Inhibition of Shh impairs angiogenesis in vivo
Inhibition of Shh impairs the up-regulation of myogenic factors and reduces the number of activated satellite cells in vivo
Shh direct effects on satellite cells in vitro and in vivo
B). Since Ptc1 is a downstream transcriptional target of Shh and its expression corresponds to LacZ expression in post-natal tissues of NLS-Ptc1-LacZ mice
), indicating that activated MSCs directly respond to Shh stimulation in injured and regenerating muscles. We also performed immunostaining for CD31 (an endothelial cell-specific marker) and alpha-SM-actin (a smooth muscle cell-specific marker) and found no co-localization with ␤-gal (data not shown). We also performed immunostaining for F4/80 (a macrophage-specific marker) and found that some macrophages were occasionally positive for ␤-gal (data not shown). However, this finding was not confirmed in other experiments and has not been included in this study. Finally, we found that some ␤-gal-positive cells were positive for vimentin, a molecule expressed by interstitial mesenchymal cells, such as undifferentiated muscle precursor cells and fibroblasts (data not shown). Following the demonstration that Shh directly induces Ptc1 upregulation in MSCs in vivo, we performed in vitro experiments to evaluate the effects of Shh treatment and inhibition on the proliferation of myoblast cells. Exposure of mouse myoblast C2C12 cells to Shh in culture resulted in significant increase in BrdU incorporation in comparison to untreated cells
These data corroborate earlier studies that have documented the ability of Shh to regulate activity and functions of MSCs in vitro [14, 25] . They also provide the first demonstration that Shh directly acts on adult MSCs in vivo.
Fig. 2 In situ hybridization for Shh after skeletal muscle injury. (A) Two days after mechanical crush, Shh expression is detectable in skeletal muscle fibres surrounding the injured area. (B) Also after CTX injection, there is strong Shh-positive signal in muscle fibres within the injured tissue.
Inhibition of Shh impairs skeletal muscle repair and functional recovery
Muscles of mice treated with cyclopamine showed a greater extent of fibrosis than controls (Fig. 6A-C) . Similarly, ET, a marker of skeletal muscle inflammatory reaction, was greater in mice treated with cyclopamine than controls ( Fig. 6D and (Fig. 6G) .
E). The ratio between ET in injured and contralateral muscles, measured 10 days after CTX injection, was significantly higher in mice treated with cyclopamine than in controls (Fig. 6F). Finally, we evaluated whether Shh function is required for efficient functional recovery after injury. CTX injection was performed unilaterally in the
Fig. 3 Inhibition of Shh reduces the angiogenic response to injury. (A) In CTX-injured muscles, local production of VEGF is significantly reduced by treatment with the Shh inhibitor cyclopamine (cyc) (#P < 0.05). (B) Cyclopamine treatment reduces the up-regulation of SDF-1alpha in CTX-injured muscles ( §P < 0.01). (C, D) BS1 lectin fluorescent staining showing reduced capillary density in muscles of mice treated cyc, compared to control animals. (E) Number of capillaries is significantly lower in the injured muscles of cyc-treated mice than in those of saline-treated controls ( §P < 0.01). (F) Laser Doppler analysis showing that local blood flow is significantly lower in muscles of mice treated with cyc than controls, at day 2, 4, 6 and 8 after injury (#P < 0.05). gastrocnemius muscle of mice treated with cyclopamine or saline. Inhibition of Shh caused significant reduction of muscle strength at day 6, 8 and 10 after injury
Discussion
In the present study, we show that the adult skeletal muscle resurrects the embryonic Shh pathway to guide regeneration after injury. The reactivation of this developmental pathway is functionally important, since its inhibition results in impaired production of angiogenic and myogenic secreted factors, decreased up-regulation of the MRFs Myf5 and MyoD, impairment of the angiogenic response to injury, reduction of the number of activated satellite cells at the damage site, increased fibrosis and inflammatory reaction and compromised muscle functional recovery.
These results were obtained by inhibiting the Shh pathway by using cyclopamine, a plant alkaloid that is able to block Shh activity by interacting with Smo [10] [11] [12] [13] . Cyclopamine does not selectively block the Shh pathway, but also inhibits the Dhh and Ihh signalling pathways [10] [11] [12] [13] . However, we have found Shh up-regulation, but no Dhh or Ihh up-regulation, in the muscle injury models used in this study. Therefore, the modifications observed in cyclopaminetreated mice have to be attributed to the inhibition of the Shh activity. In addition, we also administered cyclopamine to healthy uninjured The discovery that Shh is de novo expressed in injured adult skeletal muscle and its activity is functionally important for regeneration is consistent with the concept that, in addition to its classical role during embryogenesis, Shh participates in a number of physiologic and pathologic conditions in post-natal life. In this respect, the contribution of Shh to tissue regeneration has already been reported for heart, skin, bone, corneal epithelium, peripheral nerve and spinal cord [5, [26] [27] [28] [29] [30] [31] [32] . Our findings shed new light on fundamentally important cellular and molecular mechanisms [18, 19, 33] . In addition, VEGF promotes regeneration in transplanted skeletal muscles, plays a role in myoblast migration and survival and, following glycerol-or cardiotoxin-induced damage, markedly improves muscle fibre reconstitution [34, 35] . Very recently, it has also been shown that VEGF gene transfer promotes skeletal muscle regeneration and function in a mouse model of muscular dystrophy [36] . Other recent studies have identified SDF-1alpha as an important chemokine for muscle biology. In the embryo, the inactivation of the SDF-1alpha receptor CXCR4 results in impaired limb myogenesis [37] . SDF-1alpha is increased in certain inflammatory myopathies in the adult [38] . In post-natal life, the SDF-1alpha receptor CXCR4 is expressed by both endothelial progenitor cells and MSCs [39] . Importantly, MSCs respond to muscle-derived SDF-1alpha by activating multiple intracellular mechanisms related to chemotaxis and phosphorylation of myogenic transcription factors [39] . Taken [18, 19, [33] [34] [35] [36] . In this respect, it is intriguing to note that some VEGFand SDF-1alpha-induced intracellular mechanisms, such as the PI3K/Akt and MAP kinase signalling pathways, in addition to be important for endothelial cell survival, migration and proliferation, are also involved in muscle survival, differentiation and regeneration [48] [49] [50] [51] [52] [53] . An additional explanation for the development of fibrosis in cyclopamine-treated animals might be the decreased production of IGF-1. Indeed, IGF-1 is a protein with potent antiapoptotic functions in skeletal muscle cells [51, 54] 
Fig. 4 Inhibition of Shh decreases local production of myogenic factors and reduces the number of activated MSCs in vivo. (A) In CTX-injured muscles, local production of IGF-1 is significantly reduced by cyc (#P < 0.05). (B) Western blotting analysis showing impaired up-regulation of both Myf5 and MyoD in CTX-injured muscles of mice treated with cyc. (C) Quantification of Western blotting data by densitometric analysis showing significant difference of Myf5 and MyoD protein expression between saline-and cyc-treated animals (#P < 0.05). (D) Immunofluorescent staining for Myf5 and MyoD 4 days after CTX-injury, showing substantial reduction of both Myf5-and MyoD-positive cells in injured muscles of mice treated with cyc. (E) Quantification of Myf5 and MyoD histologic analyses, demonstrating that the number of Myf5-positive cells is significantly reduced in muscles of mice treated with cyc ( §P < 0.01). Also the number of MyoD-positive cells is significantly reduced upon inhibition of Shh activity ( §P < 0.01).
01). (D, E) Representative images of ET (blue staining) in muscles of mice treated with cyc and saline. (F) The ratio between ET at the injured and contralateral side is significantly higher in mice treated with cyc than controls ( §P < 0.01). (G) Cyc
